Takeda scraps late-stage amyloidosis study
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo (Reuters) – Takeda Pharmaceutical Co Ltd said on Wednesday…
Top lawmaker signals support to classify all illicit fentanyl copycats like heroin
WASHINGTON (Reuters) – A top U.S. Senator signaled some support on Tuesday for legislation permanently placing illicit chemical knock-offs of the extremely potent opioid fentanyl into the same legal class…
FDA approves Lilly’s migraine drug as first ever cluster headache treatment
NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks,…
U.S. health officials report 41 new cases of measles last week
(Reuters) – The United States recorded 41 new measles cases last week, bringing the year’s total number of cases to 981 in the worst outbreak of the disease since 1992,…
When shots start younger, more teens get meningococcal vaccine
(Reuters Health) – Teens are more likely to get at least one of two recommended doses of the meningococcal vaccine when they receive their first shot by early adolescence, a…
U.S. football player’s overdose death spotlighted in J&J Oklahoma opioid trial
(Reuters) – The father of a college football player who died of a drug overdose gave emotional testimony about the U.S. opioid epidemic’s personal cost on Wednesday in the second…
J&J’s greed helped fuel U.S. opioid crisis, Oklahoma claims at trial
NORMAN, Okla. (Reuters) – Johnson & Johnson’s greed led the drugmaker to use deceptive marketing to create an oversupply of painkillers that fueled the U.S. opioid epidemic, the state of…
British Columbia to be first Canadian province to switch patients to biosimilars
TORONTO/MONTREAL (Reuters) – The Canadian province of British Columbia said on Monday that its public drug plan will switch as many as 20,400 patients from three branded biologic drugs to…
Teva Pharm to pay Oklahoma $85 million to settle opioid claims
BOSTON/JERUSALEM (Reuters) – Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set…
Oklahoma reaches $85 million settlement with Teva Pharmaceuticals ahead of trial
A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad (Reuters) – Oklahoma has reached a $85 million settlement agreement…